Sound Pharmaceuticals Obtains $300,000 New Funding

  • Feed Type
  • Date
    8/20/2015
  • Company Name
    Sound Pharmaceuticals
  • Mailing Address
    4010 Stone Way N Seattle, WA 98103 USA
  • Company Description
    Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical company in Seattle, WA. Our goal is to develop prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans.
  • Website
    http://www.soundpharmaceuticals.com
  • Transaction Type
    Debt
  • Transaction Amount
    $300,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy